WHO releases target regimen profiles for long-acting injectables for TB
The World Health Organization (WHO) has published Target regimen profiles for long-acting injectables for tuberculosis prevention and treatment. Tuberculosis (TB) prevention and treatment still depend on daily oral regimens taken over months, and sustaining adherence over such periods is difficult for many people. Long-acting injectables (LAIs) could significantly lighten the burden for people taking TB medicines and the health system that delivers them. (October 2026)
Learn more